| Identification | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Pyrophosphate 2- | ||||||||||||||||||||||||||||||
| Accession Number | DB02212 (EXPT02631) | ||||||||||||||||||||||||||||||
| Type | small molecule | ||||||||||||||||||||||||||||||
| Groups | experimental | ||||||||||||||||||||||||||||||
| Description | Not Available | ||||||||||||||||||||||||||||||
| Structure |
Download: MOL | SDF | SMILES | InChI Display: 2D Structure | 3D Structure |
||||||||||||||||||||||||||||||
| Synonyms | Not Available | ||||||||||||||||||||||||||||||
| Salts | Not Available | ||||||||||||||||||||||||||||||
| Brand names | Not Available | ||||||||||||||||||||||||||||||
| Brand mixtures | Not Available | ||||||||||||||||||||||||||||||
| Categories | Not Available | ||||||||||||||||||||||||||||||
| CAS number | Not Available | ||||||||||||||||||||||||||||||
| Weight |
Average: 175.9592 Monoisotopic: 175.927575442 |
||||||||||||||||||||||||||||||
| Chemical Formula | H2O7P2 | ||||||||||||||||||||||||||||||
| InChI Key | InChIKey=XPPKVPWEQAFLFU-UHFFFAOYSA-L | ||||||||||||||||||||||||||||||
| InChI |
InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-2
Plain Text
|
||||||||||||||||||||||||||||||
| IUPAC Name |
hydrogen (hydrogen phosphonatooxy)phosphonate
|
||||||||||||||||||||||||||||||
| SMILES |
O[P@]([O-])(=O)O[P@@](O)([O-])=O
Plain Text
|
||||||||||||||||||||||||||||||
| Mass Spec | Not Available | ||||||||||||||||||||||||||||||
| Taxonomy | |||||||||||||||||||||||||||||||
| Kingdom | Not Available | ||||||||||||||||||||||||||||||
| Classes | Not Available | ||||||||||||||||||||||||||||||
| Substructures | Not Available | ||||||||||||||||||||||||||||||
| Pharmacology | |||||||||||||||||||||||||||||||
| Indication | Not Available | ||||||||||||||||||||||||||||||
| Pharmacodynamics | Not Available | ||||||||||||||||||||||||||||||
| Mechanism of action | Not Available | ||||||||||||||||||||||||||||||
| Absorption | Not Available | ||||||||||||||||||||||||||||||
| Volume of distribution | Not Available | ||||||||||||||||||||||||||||||
| Protein binding | Not Available | ||||||||||||||||||||||||||||||
| Metabolism |
Not Available
|
||||||||||||||||||||||||||||||
| Route of elimination | Not Available | ||||||||||||||||||||||||||||||
| Half life | Not Available | ||||||||||||||||||||||||||||||
| Clearance | Not Available | ||||||||||||||||||||||||||||||
| Toxicity | Not Available | ||||||||||||||||||||||||||||||
| Affected organisms | Not Available | ||||||||||||||||||||||||||||||
| Pathways | Not Available | ||||||||||||||||||||||||||||||
| Pharmacoeconomics | |||||||||||||||||||||||||||||||
| Manufacturers | Not Available | ||||||||||||||||||||||||||||||
| Packagers | Not Available | ||||||||||||||||||||||||||||||
| Dosage forms | Not Available | ||||||||||||||||||||||||||||||
| Prices | Not Available | ||||||||||||||||||||||||||||||
| Patents | Not Available | ||||||||||||||||||||||||||||||
| Properties | |||||||||||||||||||||||||||||||
| State | solid | ||||||||||||||||||||||||||||||
| Experimental Properties | Not Available | ||||||||||||||||||||||||||||||
| Predicted Properties |
|
||||||||||||||||||||||||||||||
| References | |||||||||||||||||||||||||||||||
| Synthesis Reference | Not Available | ||||||||||||||||||||||||||||||
| General Reference | Not Available | ||||||||||||||||||||||||||||||
| External Links |
|
||||||||||||||||||||||||||||||
| ATC Codes | Not Available | ||||||||||||||||||||||||||||||
| AHFS Codes | Not Available | ||||||||||||||||||||||||||||||
| PDB Entries | |||||||||||||||||||||||||||||||
| FDA label | Not Available | ||||||||||||||||||||||||||||||
| MSDS | Not Available | ||||||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||||||
| Drug Interactions | Not Available | ||||||||||||||||||||||||||||||
| Food Interactions | Not Available | ||||||||||||||||||||||||||||||
| Targets |
|---|
|
1. Inositol-3-phosphate synthase 1 Pharmacological action: unknownOrganism class: human UniProt ID: Q9NPH2 ![]() Gene: ISYNA1 SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Organism class: human UniProt ID: Q15181 ![]() Gene: PPA1 SNPs: SNPJam Report ![]() References:
3. 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase Pharmacological action: unknownConverts 4-diphosphocytidyl-2-C-methyl-D-erythritol 2- phosphate into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP (By similarity) Organism class: bacterialUniProt ID: P44815 ![]() Gene: ispF Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]()
Pharmacological action: unknown
Organism class: bacterial UniProt ID: Q9ZIV5 ![]() Protein Sequence: FASTA Gene Sequence: FASTA 5. Bifunctional adenosylcobalamin biosynthesis protein cobU Pharmacological action: unknownCatalyzes ATP-dependent phosphorylation of adenosylcobinamide and addition of GMP to adenosylcobinamide phosphate Organism class: bacterialUniProt ID: Q05599 ![]() Gene: cobU Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 6. GMP synthase [glutamine-hydrolyzing] Pharmacological action: unknownCatalyzes the synthesis of GMP from XMP Organism class: bacterialUniProt ID: P04079 ![]() Gene: guaA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 7. Hypoxanthine-guanine phosphoribosyltransferase Pharmacological action: unknownOrganism class: human UniProt ID: P00492 ![]() Gene: HPRT1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
BlaR1 is a potential penicillin-binding protein required for induction of beta-lactamase Organism class: bacterialUniProt ID: P18357 ![]() Gene: blaR1 Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 9. NH(3)-dependent NAD(+) synthetase Pharmacological action: unknownCatalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction Organism class: bacterialUniProt ID: P08164 ![]() Gene: nadE Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 10. Carboxyethyl-arginine beta-lactam-synthase Pharmacological action: unknownATP + L-2-N-(2-carboxyethyl)arginine = AMP + diphosphate + deoxyamidinoproclavaminate Organism class: bacterialUniProt ID: Q9R8E3 ![]() Gene: bls Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 11. 6-phosphogluconate dehydrogenase, decarboxylating Pharmacological action: unknown6-phospho-D-gluconate + NADP(+) = D-ribulose 5-phosphate + CO(2) + NADPH Organism class: humanUniProt ID: P52209 ![]() Gene: PGD ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Diphosphate + H(2)O = 2 phosphate Organism class: bacterialUniProt ID: P0A7A9 ![]() Gene: ppa Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 13. Nucleoside diphosphate kinase A Pharmacological action: unknownMajor role in the synthesis of nucleoside triphosphates other than ATP Organism class: humanUniProt ID: P15531 ![]() Gene: NME1 Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
14. RNA-directed RNA polymerase Pharmacological action: unknownNucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1) Organism class: viralUniProt ID: P11124 ![]() Gene: P2 Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 15. S-adenosylmethionine synthetase Pharmacological action: unknownCatalyzes the formation of S-adenosylmethionine from methionine and ATP. The overall synthetic reaction is composed of two sequential steps, AdoMet formation and the subsequent tripolyphosphate hydrolysis which occurs prior to release of AdoMet from the enzyme Organism class: bacterialUniProt ID: P0A820 ![]() Gene: metK Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 16. Thiamine-phosphate pyrophosphorylase Pharmacological action: unknownCondenses 4-methyl-5-(beta-hydroxyethyl)thiazole monophosphate (THZ-P) and 4-amino-5-hydroxymethyl pyrimidine pyrophosphate (HMP-PP) to form thiamine monophosphate (TMP) Organism class: bacterialUniProt ID: P39594 ![]() Gene: thiE Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 17. Angiogenin Pharmacological action: unknownMay function as a tRNA-specific ribonuclease that binds to actin on the surface of endothelial cells; once bound, angiogenin is endocytosed and translocated to the nucleus, thereby promoting the endothelial invasiveness necessary for blood vessel formation. Angiogenin induces vascularization of normal and malignant tissues. Abolishes protein synthesis by specifically hydrolyzing cellular tRNAs Organism class: humanUniProt ID: P03950 ![]() Gene: ANG ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 18. Hypoxanthine-guanine-xanthine phosphoribosyltransferase Pharmacological action: unknownWorks with guanine, hypoxanthine and xanthine Organism class: parasiticUniProt ID: P20035 ![]() Gene: LACZ Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 19. Folylpolyglutamate synthase Pharmacological action: unknownConversion of folates to polyglutamate derivatives. It preferes 5,10-methylenetetrahydrofolate, rather than 10- formyltetrahydrofolate as folate substrate Organism class: bacterialUniProt ID: P15925 ![]() Gene: fgs Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 20. Myosin-14 Pharmacological action: unknownCellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping (By similarity) Organism class: humanUniProt ID: Q7Z406 ![]() Gene: MYH14 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
|
| Comments |
|---|